Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Study ID
- NCT00999791
- Phase
- PHASE1
- Status
- Unknown
Conditions
- Diffuse Diabetic Macular Edema
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab — DRUG
- Diclofenac — DRUG
Study Details
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.
Key Dates
- First listed
- Oct 22, 2009
- Start date
- Jul 31, 2009
- Status verified
- Oct 2009
Study Design
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Avastin
- Active Comparator: Diclofenac
Central Contacts
- Masoud Soheilian, MD+982122585952